Cite
Supplementary Figures S1-S5 from αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4
MLA
Tsuneo Saga, et al. Supplementary Figures S1-S5 from ΑVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-Cyclam-RAFT-c(-RGDfK-)4. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2de10b558181714d86589896202c196c&authtype=sso&custid=ns315887.
APA
Tsuneo Saga, Pascal Dumy, Didier Boturyn, Ming-Rong Zhang, Yasuhisa Fujibayashi, Kazunori Kawamura, Tomoteru Yamasaki, Atsushi B. Tsuji, Aya Sugyo, Mélissa Degardin, Takako Furukawa, & Zhao-Hui Jin. (2023). Supplementary Figures S1-S5 from αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4.
Chicago
Tsuneo Saga, Pascal Dumy, Didier Boturyn, Ming-Rong Zhang, Yasuhisa Fujibayashi, Kazunori Kawamura, Tomoteru Yamasaki, et al. 2023. “Supplementary Figures S1-S5 from ΑVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-Cyclam-RAFT-c(-RGDfK-)4,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2de10b558181714d86589896202c196c&authtype=sso&custid=ns315887.